Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 9/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.36 |
| ▸ | PIM1 | P11309 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6864393 | 0.90 | DRD2 (0.41) | DRD2 | |
| SCHEMBL6607362 | 0.83 | GALR1 (0.39) | DRD2 | |
| SCHEMBL5553539 | 0.83 | DRD2 (0.39) | DRD2PIM1 | |
| SCHEMBL6430113 | 0.83 | VNN1 (0.33) | DRD2 | |
| SCHEMBL5554025 | 0.83 | GALR1 (0.38) | DRD2 | |
| SCHEMBL5553593 | 0.80 | DRD2 (0.38) | DRD2 | |
| SCHEMBL6427953 | 0.80 | KDM4E (0.33) | DRD2 | |
| SCHEMBL5428655 | 0.79 | GALR1 (0.33) | DRD2 | |
| SCHEMBL6231594 | 0.79 | KDM4E (0.35) | DRD2 | |
| SCHEMBL6429771 | 0.79 | MCHR1 (0.33) | DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050124619-A1 | Medical devices employing triazine compounds and compositions thereof | DR. REDDY'S LABORATORIES LTD. (IN) | 2005-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124619-A1 | Medical devices employing triazine compounds and compositions thereof | PTGIS, AREG, TGFB1 | DRD2 4763/4885ABCG2 4462/4885PIM1 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.